PATENT CLAIM ANALYSIS

Application Number: 16282120
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-07
Patent Classification: ["424", "145100"]

Abstract:
Methods are disclosed for treating osteoarthritis in a human subject in need thereof, comprising administering to the subject a therapeutically effective amount of an anti-human NGF antibody, or antigen-binding fragment thereof, wherein at least one symptom associated with osteoarthritis is prevented, ameliorated or improved.

Claim (Index 32):
The method of  claim 31 , wherein the NGF-related condition is post-herpetic neuralgia.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 99.0
- Lexical Diversity: 1.225
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14038349', '13648477', '12888751', '15144574', '12188330']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8111145927373239
- 35 USC 102 Novelty (BERT): 0.5916493523635524
- Combined Prediction Score: 0.7891680686999467
- Mean Citation Score: 529.2572640000002
- Max Citation Score: 573.95435
- Similarity Product: 397.2520331258416

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test